Login Register Cart 0
Generic placeholder image

Pharmaceutical Nanotechnology

Editor-in-Chief

ISSN (Print): 2211-7385
ISSN (Online): 2211-7393

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

A Comparative Analysis of Methods for Titering Reovirus

Author(s): Yi-Chen Yang, Xian-Yao Wang, Yuan-Yuan An, Chun-Xiang Liao, Nian-Xue Wang, Xing-Zhao* and Zhi-Xu He*

Volume 8, Issue 5, 2020

Page: [409 - 417] Pages: 9

DOI: 10.2174/2211738508666200826103322

Price: $65

Abstract

Background: A key challenge in the process of virus amplification is the need for a simple and convenient method for measuring virus titers.

Objective: Real-time unlabeled cell analysis (RTCA) was used to establish a standard curve of correlation between half-cell index time (CIT50) and virus titer. At the same time, the virus titer from tunable resistance pulse detection (TRPS) technology was compared with the traditional median tissue culture infectious dose (TCID50) method to evaluate the feasibility and application value of the RTCA technique and TRPS technology.

Methods: Cell index (CI) values for L929 cells under different culture conditions were detected, and the appropriate initial cell inoculation density was screened. The half-cell index (CI50) values of reovirus infected L929 cells with TCID50 titers were analyzed by RTCA, the CI50-TCID50 standard curve was created, and a regression equation was developed. RTCA, TCID50, and TRPS methods were used to detect the reovirus titer obtained by the amplification, and the sensitivity and feasibility of the CIT50-TCID50 standard curve method were analyzed. The virus titer was detected by TRPS technology and the TCID50 method.

Results: L929 cells were best propagated at an initial density of 6 × 103 cells/well. After infecting L929 cells with different titers of reference reovirus, the linear correlation of CIT50 and TCID50 was y = -2.1806x + 71.023 (R2 = 0.9742). The titer resulting from the RTCA assay was 7×109.6821 pfu/mL, from the TRPS assay was 4.52×1010 pfu/mL, and from the TCID50 assay was 7×109.467 pfu/mL.

Conclusion: The CIT50-TCID50 standard curve method established by the RTCA technique can be used to quantitatively detect reovirus titer with L929 cells. Compared with the TCID50 method, it takes a relatively short time and has high sensitivity and accuracy. The TRPS technology requires even less time to quantify the virus, but its precision is lower than that of the TCID50 method and RTCA technology. This study provides new technical methods for assessing the virulence of infectious live reovirus particles.

Lay Summary: After amplification of the virus, we need to detect the virus titers (the virulence of the virus). The traditional method is to use the virus to infect cells, and then the virus titers can be calculated by 50% of the cells infected. However, this traditional method is time consuming. The ways of RTCA (a real-time cell analysis technique) and TRPS (a nano-bioparticle analysis technique) help us to detect viral titers. The consistency of these three methods determines their feasibility and accuracy. If they are feasible, then these two simple technologies will provide new ideas for detecting viral titers.

Keywords: Cytolytic effect, reovirus, RTCA technique, TCID50, TRPS, virus titer.

« Previous Next »
Graphical Abstract

[1]
Howells A, Marelli G, Lemoine NR, Wang Y. Oncolytic viruses-interaction of virus and tumor cells in the battle to eliminate cancer. Front Oncol 2017; 7: 195.
[2]
Hamano S, Mori Y, Aoyama M, Kataoka H, Letters TJJC. Oncolytic reovirus combined with trastuzumab enhances antitumor efficacy through TRAIL signaling in human HER2-positive gastric cancer cells 2014; 356(2): 846-54.
[3]
Duncan R, Horne D, Cashdollar LW, Joklik WK, Lee PWKJV. Identification of conserved domains in the cell attachment proteins of the three serotypes of reovirus 1990; 174(2): 399-409.
[http://dx.doi.org/10.1016/0042-6822(90)90093-7]
[4]
Lolkema MP, Arkenau HT, Harrington , et al. A phase i study of the combination of intravenous reovirus type 3 dearing and gemcitabine in patients with advanced cancer. Clin Cancer Res 2011; 17(3): 581-8.
[5]
Karapanagiotou EM, Roulstone V, Twigger K, et al. Phase I/II trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic reovirus in patients with advanced malignancies. Clin Cancer Res 2012; 18(7): 2080-9.
[6]
Labarre DD, Lowy RJ. Improvements in methods for calculating virus titer estimates from TCID50 and plaque assays. J Virol Methods 2001; 96(2): 107-26.
[7]
Munro SB, Kuypers J, Jerome KR. Comparison of a multiplex real-time PCR assay with a multiplex luminex assay for influenza virus detection. J Clin Microbiol 2013; 51(4): 1124-9.
[8]
Fang Y, Ye P, Wang X, Xu X, Reisen W. Real-time monitoring of flavivirus induced cytopathogenesis using cell electric impedance technology. J Virol Methods 2011; 173(2): 251-8.
[9]
Tian D, Zhang W, He J, et al. Novel, real-time cell analysis for measuring viral cytopathogenesis and the efficacy of neutralizing antibodies to the 2009 influenza A (H1N1) virus. PLoS One 2012; 7(2)e31965
[10]
Zheng T, Kuang X, Wang J, Zhang X. Real-time cell analysis - a new method for dynamic, quantitative measurement of infectious viruses and antiserum neutralizing activity. J Virol Methods 2013; 193(2): 364-70.
[11]
Liying Z, Yiyan S, Chen Jin C, et al. A general method to regenerate arrayed gold microelectrodes for label-free cell assay. Anal Biochem 2017; 516: 57-60.
[12]
Xu Z, Song Y, Jiang H, Kong Y, Li X, Chen J, et al. Regeneration of arrayed gold microelectrodes equipped for a real-time cell analyzer. J Vis Exp 2018; (133): e56250
[13]
Xu Z, Cai L, Jiang H, et al. Real-time cell analysis of the cytotoxicity of a pH-responsive drug-delivery matrix based on mesoporous silica materials functionalized with ferrocenecarboxylic acid. Anal Chim Acta 2019; 1051: 138-46.
[14]
Maas SLN, Broekman MLD, Vrij J. Tunable resistive pulse sensing for the characterization of extracellular vesicle. New York: Humana Press 2017; pp. 21-33.
[http://dx.doi.org/10.1007/978-1-4939-6728-5_2]
[15]
Roberts GS, Kozak D, Anderson W, Broom MF, Vogel R, Trau M. Tunable nano/micropores for particle detection and discrimination: scanning ion occlusion spectroscopy. Small 2010; 6(23): 2653-8.
[16]
Roberts GS, Yu S, Zeng Q, et al. Tunable pores for measuring concentrations of synthetic and biological nanoparticle dispersions. Biosens Bioelectron 2012; 31(1): 17-25.
[17]
Zandi K. A real-time cell analyzing assay for identification of novel antiviral compounds against chikungunya virus. Methods Mol Biol 2016; 1426: 255-62.
[http://dx.doi.org/10.1007/978-1-4939-3618-2_23] [PMID: 27233278]
[18]
Cho S, Becker S, Briesen HV, Thielecke H. Impedance monitoring of herpes simplex virus-induced cytopathic effect in Vero cells. Sens Act B 2007; B123(2): 978-82.
[19]
Marlina S, Shu MH, Abubakar S, Zandi KJP. Development of a real-time cell analysing (RTCA) method as a fast and accurate screen for the selection of chikungunya virus replication inhibitors 2015; 8(1): 1-10.
[20]
Lebourgeois S, Fraisse A, Hennechart-Collette C, Guillier L, Perelle S, Martin-Latil S. Development of a real-time cell analysis (RTCA) method as a fast and accurate method for detecting infectious particles of the adapted strain of hepatitis. Front Cell Infect Microbiol 2018; 8: 335.

Rights & Permissions Print Cite
Article Metrics
37
© 2024 Bentham Science Publishers | Privacy Policy